These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 31347976

  • 21. Down-regulation of lncRNA Gas5 promotes hypoxia-induced pulmonary arterial smooth muscle cell proliferation by regulating KCNK3 expression.
    Hao X, Li H, Zhang P, Yu X, Jiang J, Chen S.
    Eur J Pharmacol; 2020 Dec 15; 889():173618. PubMed ID: 33010302
    [Abstract] [Full Text] [Related]

  • 22. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S, Houssaïni A, Mouraret N, Marcos E, Amsellem V, Wan F, Dubois-Randé JL, Derumeaux G, Boczkowski J, Motterlini R, Adnot S.
    Arterioscler Thromb Vasc Biol; 2014 Feb 15; 34(2):304-12. PubMed ID: 24334871
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of RELM-β prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing PLC-mediated KCNK3 decline.
    Han L, Song N, Hu X, Zhu A, Wei X, Liu J, Yuan S, Mao W, Chen X.
    Life Sci; 2020 Apr 01; 246():117419. PubMed ID: 32045592
    [Abstract] [Full Text] [Related]

  • 24. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H, Hudalla H, Michael Z, Filatava EJ, Li J, Zhu M, Possomato-Vieira JS, Dias-Junior C, Kourembanas S, Khalil RA.
    J Pharmacol Exp Ther; 2018 Feb 01; 364(2):258-274. PubMed ID: 29212831
    [Abstract] [Full Text] [Related]

  • 25. TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries.
    Murtaza G, Mermer P, Goldenberg A, Pfeil U, Paddenberg R, Weissmann N, Lochnit G, Kummer W.
    PLoS One; 2017 Feb 01; 12(3):e0174071. PubMed ID: 28301582
    [Abstract] [Full Text] [Related]

  • 26. TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.
    Seyler C, Duthil-Straub E, Zitron E, Gierten J, Scholz EP, Fink RH, Karle CA, Becker R, Katus HA, Thomas D.
    Br J Pharmacol; 2012 Mar 01; 165(5):1467-75. PubMed ID: 21838752
    [Abstract] [Full Text] [Related]

  • 27. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
    Xia S, Tai X, Wang Y, An X, Qian G, Dong J, Wang X, Sha B, Wang D, Murthi P, Kalionis B, Wang X, Bai C.
    Am J Respir Cell Mol Biol; 2011 Jan 01; 44(1):66-73. PubMed ID: 20160044
    [Abstract] [Full Text] [Related]

  • 28. Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension.
    Guihaire J, Deuse T, Wang D, Spin JM, Blankenberg FG, Fadel E, Reichenspurner H, Schrepfer S.
    Stem Cells Dev; 2021 May 15; 30(10):515-525. PubMed ID: 33726521
    [Abstract] [Full Text] [Related]

  • 29. Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.
    Alvarez RA, Miller MP, Hahn SA, Galley JC, Bauer E, Bachman T, Hu J, Sembrat J, Goncharov D, Mora AL, Rojas M, Goncharova E, Straub AC.
    Am J Respir Cell Mol Biol; 2017 Dec 15; 57(6):733-744. PubMed ID: 28800253
    [Abstract] [Full Text] [Related]

  • 30. Baicalein Ameliorates Pulmonary Arterial Hypertension Caused by Monocrotaline through Downregulation of ET-1 and ETAR in Pneumonectomized Rats.
    Hsu WL, Lin YC, Jeng JR, Chang HY, Chou TC.
    Am J Chin Med; 2018 Dec 15; 46(4):769-783. PubMed ID: 29737212
    [Abstract] [Full Text] [Related]

  • 31. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH, Mižíková I, Niess G, Steenbock H, Reichenberger F, Talavera ML, Veit F, Herold S, Mayer K, Vadász I, Weissmann N, Seeger W, Brinckmann J, Morty RE.
    Arterioscler Thromb Vasc Biol; 2014 Jul 15; 34(7):1446-58. PubMed ID: 24833797
    [Abstract] [Full Text] [Related]

  • 32. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
    Redel-Traub G, Sampson KJ, Kass RS, Bohnen MS.
    Biomolecules; 2022 Sep 22; 12(10):. PubMed ID: 36291551
    [Abstract] [Full Text] [Related]

  • 33. TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.
    Olschewski A, Veale EL, Nagy BM, Nagaraj C, Kwapiszewska G, Antigny F, Lambert M, Humbert M, Czirják G, Enyedi P, Mathie A.
    Eur Respir J; 2017 Nov 22; 50(5):. PubMed ID: 29122916
    [Abstract] [Full Text] [Related]

  • 34. Periostin Mediates Right Ventricular Failure through Induction of Inducible Nitric Oxide Synthase Expression in Right Ventricular Fibroblasts from Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.
    Imoto K, Okada M, Yamawaki H.
    Int J Mol Sci; 2018 Dec 24; 20(1):. PubMed ID: 30586863
    [Abstract] [Full Text] [Related]

  • 35. Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension.
    Chen H, Yang H, Yue H, Strappe PM, Xia P, Pan L, Zhang Y, Chai S, Chen S, Ma L, Wang L.
    Heart Lung Circ; 2017 May 24; 26(5):509-518. PubMed ID: 27771236
    [Abstract] [Full Text] [Related]

  • 36. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.
    Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P, Eddahibi S.
    Am J Respir Cell Mol Biol; 2000 Dec 24; 23(6):762-71. PubMed ID: 11104729
    [Abstract] [Full Text] [Related]

  • 37. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, Rücker-Martin C, Antigny F, Nakhleh MK, Ranchoux B, Gouadon E, Vinhas MC, Vocelle M, Raymond N, Dorfmüller P, Fadel E, Perros F, Humbert M, Cohen-Kaminsky S.
    Circulation; 2018 May 29; 137(22):2371-2389. PubMed ID: 29444988
    [Abstract] [Full Text] [Related]

  • 38. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
    Zhu R, Bi LQ, Wu SL, Li L, Kong H, Xie WP, Wang H, Meng ZL.
    Mol Med Rep; 2015 Aug 29; 12(2):2945-52. PubMed ID: 25936382
    [Abstract] [Full Text] [Related]

  • 39. Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.
    Franz M, Grün K, Betge S, Rohm I, Ndongson-Dongmo B, Bauer R, Schulze PC, Lichtenauer M, Petersen I, Neri D, Berndt A, Jung C.
    Oncotarget; 2016 Dec 06; 7(49):81241-81254. PubMed ID: 27835899
    [Abstract] [Full Text] [Related]

  • 40. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S, Haraguchi G, Sasaki A, Arai H, Muto S, Itai A, Doi S, Mizutani S, Isobe M.
    Cardiovasc Res; 2013 Jul 01; 99(1):35-43. PubMed ID: 23631839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.